chr3-190387530-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001378492.1(CLDN16):​c.-93-707G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 152,144 control chromosomes in the GnomAD database, including 3,084 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.19 ( 3084 hom., cov: 33)

Consequence

CLDN16
NM_001378492.1 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.52

Publications

0 publications found
Variant links:
Genes affected
CLDN16 (HGNC:2037): (claudin 16) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. It is found primarily in the kidneys, specifically in the thick ascending limb of Henle, where it acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions. Defects in this gene are a cause of primary hypomagnesemia, which is characterized by massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. This gene and the CLDN1 gene are clustered on chromosome 3q28. [provided by RefSeq, Jun 2010]
CLDN16 Gene-Disease associations (from GenCC):
  • renal hypomagnesemia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-190387530-G-A is Benign according to our data. Variant chr3-190387530-G-A is described in ClinVar as Benign. ClinVar VariationId is 1229364.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.241 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378492.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN16
NM_001378492.1
c.-93-707G>A
intron
N/ANP_001365421.1Q9Y5I7
CLDN16
NM_001378493.1
c.-93-707G>A
intron
N/ANP_001365422.1Q9Y5I7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLDN16
ENST00000880223.1
c.-93-707G>A
intron
N/AENSP00000550282.1
CLDN16
ENST00000880225.1
c.-93-707G>A
intron
N/AENSP00000550284.1
CLDN16
ENST00000880227.1
c.-93-707G>A
intron
N/AENSP00000550286.1

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28350
AN:
152026
Hom.:
3085
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0905
Gnomad AMI
AF:
0.188
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.0262
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.259
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.212
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.186
AC:
28362
AN:
152144
Hom.:
3084
Cov.:
33
AF XY:
0.186
AC XY:
13869
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0906
AC:
3761
AN:
41502
American (AMR)
AF:
0.175
AC:
2669
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
933
AN:
3466
East Asian (EAS)
AF:
0.0265
AC:
137
AN:
5178
South Asian (SAS)
AF:
0.168
AC:
809
AN:
4826
European-Finnish (FIN)
AF:
0.259
AC:
2738
AN:
10574
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16619
AN:
67994
Other (OTH)
AF:
0.208
AC:
440
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1175
2350
3526
4701
5876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.207
Hom.:
444
Bravo
AF:
0.172
Asia WGS
AF:
0.0890
AC:
312
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.10
DANN
Benign
0.38
PhyloP100
-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62278698; hg19: chr3-190105319; API